MedTrace Logo

Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia

NCT07056933 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-07-09

No results posted yet for this study

Summary

The aim of the study is to evaluate the therapeutic efficiency of minoxidil solution iontophoresis on Androgenic Alopecia.

Conditions

Interventions

OTHER

Minoxidil solution iontophoresis

The half of the scalp of the participants will be treated with 5% minoxidil solution through Iontophoresis that will be applied at small low voltage (typically 10 V or less) continuous constant current (typically 0.5 mA/cm2 or less) to push a charged drug into skin or other tissue, twice daily at home.

OTHER

saline solution iontophoresis

The other half of the scalp of the participants will be treated with placebo saline solution ( control) with the current application.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Heba Abdelgayed · Cairo University

  • Amal Abd Elbaky, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-08
Primary Completion
2025-11-15
Completion
2025-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07056933 on ClinicalTrials.gov